Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Circ Arrhythm Electrophysiol ; 6(6): 1192-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24243784

ABSTRACT

BACKGROUND: Previous studies showed that endocardial activation during long-duration ventricular fibrillation (VF) exhibits organized activity. We identified and quantified the different types of organized activity. METHODS AND RESULTS: Two 64-electrode basket catheters were inserted, respectively, into the left ventricle and right ventricle of dogs to record endocardial activation from the endocardium during 7 minutes of VF (controls, n=6). The study was repeated with the K(ATP) channel opener pinacidil (n=6) and the calcium channel blocker flunarizine (n=6). After 2 minutes of VF without drugs, 2 highly organized left ventricular endocardial activation patterns were observed: (1) ventricular electric synchrony pattern, in which endocardial activation arose focally and either had a propagation sequence similar to sinus rhythm or arose near papillary muscles, and (2) stable pattern, in which activation was regular and repeatable, sometimes forming a stable re-entrant circuit around the left ventricular apex. Between 3 and 7 minutes of VF, the percent of time ventricular electric synchrony was present was control=25%, flunarizine=24% (P=0.44), and pinacidil=0.1% (P<0.001) and the percent of time stable pattern was present was control=71%, flunarizine=48% (P<0.001), and pinacidil=56% (P<0.001). The remainder of the time, nonstable re-entrant activation with little repeatability was present. CONCLUSIONS: After 3 minutes, VF exhibits 2 highly organized endocardial activation patterns 96% of the time, one potentially arising focally in the Purkinje system that was prevented with a K(ATP) channel opener but not a calcium channel blocker and the other potentially arising from a stable re-entrant circuit near the apical left ventricular endocardium.


Subject(s)
Heart Conduction System/physiopathology , Purkinje Fibers/physiology , Ventricular Fibrillation/physiopathology , Animals , Calcium Channel Blockers/pharmacology , Death, Sudden, Cardiac , Dogs , Electrophysiologic Techniques, Cardiac , Endocardium/physiopathology , Female , Flunarizine/pharmacology , Heart Conduction System/drug effects , KATP Channels/drug effects , Male , Pinacidil/pharmacology , Ventricular Fibrillation/pathology
2.
Am J Physiol Heart Circ Physiol ; 302(4): H992-H1002, 2012 Feb 15.
Article in English | MEDLINE | ID: mdl-22180655

ABSTRACT

Quantitative analysis has demonstrated five temporal stages of activation during the first 10 min of ventricular fibrillation (VF) in dogs. To determine whether these stages exist in another species, we applied the same analysis to the first 10 min of VF recorded in vivo from two 504-electrode arrays, one each on left anterior and posterior ventricular epicardium in six anesthetized pigs. The following descriptors were continuously quantified: 1) number of wavefronts, 2) wavefront fractionations, 3) wavefront collisions, 4) repeatability, 5) multiplicity index, 6) wavefront conduction velocity, 7) activation rate, 8) mean area activated by the wavefronts, 9) negative peak rate of voltage change, 10) incidence of breakthrough/foci, 11) incidence of block, and 12) incidence of reentry. Cluster analysis of these descriptors divided VF into four stages (stages i-iv). The values of most descriptors increased during stage i (1-22 s after VF induction), changed quickly to values indicating greater organization during stage ii (23-39 s), decreased steadily during stage iii (40-187 s), and remained relatively unchanged during stage iv (188-600 s). The epicardium still activated during stage iv instead of becoming silent as in dogs. In conclusion, during the first 10 min, VF activation can be divided into four stages in pigs instead of five stages as in dogs. Following a 16-s period during the first minute of VF when activation became more organized, all parameters exhibited progressive decreased organization. Further studies are warranted to determine whether these changes, particularly the increased organization of stage ii, have clinical consequences, such as alteration in defibrillation efficacy.


Subject(s)
Disease Models, Animal , Electrophysiologic Techniques, Cardiac , Ventricular Fibrillation/physiopathology , Animals , Electric Stimulation , Electrocardiography , Female , Heart Ventricles/physiopathology , Male , Pericardium/physiopathology , Swine
3.
J Cardiovasc Pharmacol ; 57(3): 302-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21266917

ABSTRACT

Vernakalant is a novel antiarrhythmic agent that has demonstrated clinical efficacy for the treatment of atrial fibrillation. Vernakalant blocks, to various degrees, cardiac sodium and potassium channels with a pattern that suggests atrial selectivity. We hypothesized, therefore, that vernakalant would affect atrial more than ventricular effective refractory period (ERP) and have little or no effect on ventricular defibrillation threshold (DFT). Atrial and ventricular ERP and ventricular DFT were determined before and after treatment with vernakalant or vehicle in 23 anesthetized male mixed-breed pigs. Vernakalant was infused at a rate designed to achieve stable plasma levels similar to those in human clinical trials. Atrial and ventricular ERP were determined by endocardial extrastimuli delivered to the right atria or right ventricle. Defibrillation was achieved using external biphasic shocks delivered through adhesive defibrillation patches placed on the thorax after 10 seconds of electrically induced ventricular fibrillation. The DFT was estimated using the Dixon "up-and-down" method. Vernakalant significantly increased atrial ERP compared with vehicle controls (34 ± 8 versus 9 ± 7 msec, respectively) without significantly affecting ventricular ERP or DFT. This is consistent with atrial selective actions and supports the conclusion that vernakalant does not alter the efficacy of electrical defibrillation.


Subject(s)
Anisoles/pharmacology , Anti-Arrhythmia Agents/pharmacology , Heart Atria/drug effects , Potassium Channels/drug effects , Pyrrolidines/pharmacology , Refractory Period, Electrophysiological/drug effects , Sodium Channels/drug effects , Ventricular Function/drug effects , Animals , Anisoles/blood , Anisoles/pharmacokinetics , Anti-Arrhythmia Agents/blood , Anti-Arrhythmia Agents/pharmacokinetics , Disease Models, Animal , Drug Evaluation, Preclinical , Electric Countershock , Heart Atria/pathology , Humans , Male , Pyrrolidines/blood , Pyrrolidines/pharmacokinetics , Swine , Ventricular Function/physiology
4.
Am J Physiol Heart Circ Physiol ; 298(6): H2046-53, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20382862

ABSTRACT

Little is known about the three-dimensional (3-D) intramural activation sequences during long-duration ventricular fibrillation (VF), including the role of the subendocardium and its Purkinje fibers (PFs) in long-duration VF maintenance. Our aim was to explore the mechanism of long-duration VF maintenance with 3-D electrical mapping. We recorded 10 min of electrically induced VF in the left ventricular anterior free wall of six 10-kg, open-chest dogs using a 3-D transmural unipolar electrode matrix (9 x 9 x 6, 2-mm spacing) that allowed us to map intramural activation sequences. At 2.5 + or - 1.8 min of VF, although the body surface ECG continued to exhibit a disorganized VF pattern, intramurally a more organized, synchronous activation pattern was first observed [locally synchronized VF (LSVF)]. This pattern occurred one or more times in all dogs and was present 33.4 + or - 31.4% of the time during 5-10 min of VF. As opposed to the preceding changing complex activation sequences of VF, during LSVF, wavefronts were large and highly repeatable near the endocardium, first exciting the endocardium almost simultaneously and then rapidly spreading toward the epicardium with different levels of conduction block en route. During LSVF, PF activations always preceded working myocardium activations near the endocardium. In conclusion, long-duration VF in dogs frequently becomes highly organized in the subendocardium, with activation fronts arising in this region and passing intramurally toward the epicardium, even though the surface ECG continues to exhibit a disorganized pattern. PFs appear to play an important role during this stage of VF.


Subject(s)
Heart Conduction System/physiology , Heart/physiopathology , Ventricular Fibrillation/physiopathology , Animals , Body Surface Potential Mapping , Disease Models, Animal , Dogs , Electrocardiography , Electrophysiologic Techniques, Cardiac , Endocardium/physiology , Female , Male , Purkinje Fibers/physiology , Time Factors
5.
Heart Rhythm ; 6(3): 378-84, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19251215

ABSTRACT

BACKGROUND: Cycle length (CL) increases as ventricular fibrillation (VF) progresses. OBJECTIVE: The purpose of this study was to test the hypotheses that increased CL is due to increased diastolic interval (DI), not increased action potential duration (APD), and that the DI increase is not solely due to increased postrepolarization refractoriness. METHODS: In 10 swine, VF was recorded for 20 minutes using a floating microelectrode through a hole in a 504-electrode epicardial plaque. Mean APD, DI, action potential amplitude (APA), maximum change in voltage during the AP upstroke (V(max)), and CL were calculated from the floating microelectrode recordings each minute of VF. The refractory period was estimated from the minimum DI (DI(min)). In two animals, rapid pacing was performed to gauge refractoriness. RESULTS: As VF progressed, CL, DI, and DI(min) increased (P <.05), whereas APD, V(max), and APA decreased (P <.05). At 20 minutes, DI(min) was not different from mean DI at VF onset. Pacing captured, but 53% of paced wavefronts blocked within the plaque. CONCLUSION: Increasing CL in VF is due to increased DI and not APD, which shortens. The increase in DI(min) over time is much less than the increase in mean DI, indicating that the myocardium is excitable during much of the DI. This finding, along with the ability to pace at a CL shorter than the native VF CL and the poor paced wavefront propagation, suggests that the increase in DI is due not only to increased postrepolarization refractoriness but also to poor wavefront propagation because of decreased APA and V(max) secondary to global ischemia caused by VF.


Subject(s)
Action Potentials , Diastole , Ventricular Fibrillation/physiopathology , Animals , Cardiac Pacing, Artificial , Electrocardiography , Electrophysiologic Techniques, Cardiac , Heart Conduction System/physiopathology , Microelectrodes , Myocardial Contraction , Sus scrofa
6.
Heart Rhythm ; 6(3): 405-15, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19251220

ABSTRACT

Ventricular fibrillation (VF), despite its declining incidence as a cause of sudden cardiac death, is still a major health problem. The underlying mechanisms for the maintenance of VF are still disputed. Studies suggest that VF is unlikely one static mechanism but rather a dynamic process of electrical derangement that changes with duration. The 2 principal proposed mechanisms of VF are multiple wavelets and mother rotors. Most studies of these proposed mechanisms for VF maintenance have been during the first minute of VF. However, the time to external defibrillation in the community and pre-hospital settings, where the majority of sudden cardiac death occurs, ranges from 4 to 10 min and the time to defibrillation seems crucial because the odds of survival worsen with delay. Recent studies during the first 10 min of VF suggest that Purkinje fibers are important in maintaining VF after the first 1 to 2 min, either as a part of a reentrant circuit or as a source of focal activations.


Subject(s)
Ventricular Fibrillation/physiopathology , Animals , Electrocardiography , Electrophysiologic Techniques, Cardiac , Heart Conduction System/physiopathology , Humans , Purkinje Fibers/physiopathology
7.
Am J Forensic Med Pathol ; 28(3): 195-201, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17721165

ABSTRACT

There is only a small amount of experimental data about whether the TASER X26, a nonlethal weapon that delivers a series of brief electrical pulses to cause involuntary muscular contraction to temporarily incapacitate an individual, can initiate ventricular fibrillation to cause sudden cardiac arrest either immediately or sometime after its use. Therefore, this paper uses the fundamental law of electrostimulation and experimental data from the literature to estimate the likelihood of such events. Because of the short duration of the TASER pulses, the large duration of the cardiac cell membrane time constant, the small fraction of current from electrodes on the body surface that passes through the heart, and the resultant high pacing threshold from the body surface, the fundamental law of electrostimulation predicts that the TASER pulses will not stimulate an ectopic beat in the large majority of normal adults. Since the immediate initiation of ventricular fibrillation in a normal heart requires a very premature stimulated ectopic beat and the threshold for such premature beats is higher than less premature beats, it is unlikely that TASER pulses can immediately initiate ventricular fibrillation in such individuals through the direct effect of the electric field generated through the heart by the TASER. In the absence of preexisting heart disease, the delayed development of ventricular fibrillation requires the electrical stimuli to cause electroporation or myocardial necrosis. However, the electrical thresholds for electroporation and necrosis are many times higher than that required to stimulate an ectopic beat. Therefore, it is highly unlikely that the TASER X26 can cause ventricular fibrillation minutes to hours after its use through direct cardiac effects of the electric field generated by the TASER.


Subject(s)
Electric Stimulation/instrumentation , Heart Arrest , Animals , Cell Membrane , Electrodes , Forensic Medicine , Heart/physiology , Humans , Membrane Potentials/physiology , Myocytes, Cardiac/physiology , Time Factors , Ventricular Fibrillation/physiopathology
8.
Heart Rhythm ; 4(5): 665-74, 2007 May.
Article in English | MEDLINE | ID: mdl-17467640

ABSTRACT

I am deeply grateful and honored to receive the 2006 Distinguished Scientist Award from the Heart Rhythm Society. Many outstanding individuals have received this award since it was established in 1982, and it is humbling to realize that my small feet are walking in the footsteps of these giants. I would be remiss if I did not thank the numerous colleagues, fellows, and students who performed most of the work leading to the papers of which I am a coauthor.


Subject(s)
Ventricular Fibrillation/physiopathology , Ventricular Fibrillation/therapy , Action Potentials , Animals , Cardiac Pacing, Artificial , Defibrillators, Implantable , Electric Countershock/instrumentation , Electric Countershock/methods , Electrophysiologic Techniques, Cardiac/methods , Heart Conduction System/physiopathology , Humans , Purkinje Fibers/physiopathology
9.
Conf Proc IEEE Eng Med Biol Soc ; 2006: 3927-30, 2006.
Article in English | MEDLINE | ID: mdl-17946588

ABSTRACT

Plunge needle recording techniques have provided valuable insights into transmural activation in cardiac tissue. Construction of plunge needles has been a costly and time intensive endeavor. Plunge needles constructed with standard printed circuit board (PCB) technology and methods are outlined. PCB plunge needles are less expensive in terms of raw materials and time required for construction than hypodermic stock or epoxy plunge needles. Tested PCB plunge needles recorded signals comparable to signals recorded by other plunge needles. PCB plunge needles provide an economical and rapid alternative to previously published techniques for plunge needle design.


Subject(s)
Heart/physiology , Ventricular Function , Body Surface Potential Mapping , Electrocardiography , Electrodes , Electrophysiologic Techniques, Cardiac , Heart Conduction System , Humans , Needles
10.
J Neurosurg ; 102(2 Suppl): 213-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-16156232

ABSTRACT

OBJECT: Vagus nerve stimulation is known to decrease the frequency, duration, and intensity of some types of intracranial seizures in both humans and animals. Although many theories abound concerning the mechanism for this action, the true cause remains speculative. To potentially elucidate a pathway in which vagus nerve stimulation aborts seizure activity, seizures were initiated not in the cerebral cortex but in the spinal cord and then vagus nerve stimulation was performed. METHODS: Ten pigs were anesthetized and placed in the lateral position, and a small laminectomy was performed in the lumbar region. Topical penicillin, a known epileptogenic drug to the cerebral cortex and spinal cord, was applied to the dorsal surface of the exposed cord. With the exception of two animals that were used as controls, once seizure activity was discernible via motor convulsion or increased electrical activity the left vagus nerve, which had been previously isolated in the neck, was stimulated. Following multiple stimulations of the vagus nerve and with seizure activity confirmed, the cord was transected in the midthoracic region and vagus nerve stimulation was performed. Vagus nerve stimulation resulted in cessation of spinal cord seizure activity in all (87.5%) but one experimented animal. Transection of the spinal cord superior to the site of seizure induction resulted in the ineffectiveness of vagus nerve stimulation to cause cessation of seizure activity in all study animals. CONCLUSIONS: The effects of vagus nerve stimulation on induced spinal cord seizures involve descending spinal pathways. The authors believe that this experiment is the first to demonstrate that spinal cord neuronal hyperactivity can be suppressed by stimulation of a cranial nerve. These data may aid in the development of alternative mechanisms for electrical stimulation in patients with medically intractable seizures. Further studies are now necessary to isolate which specific tracts, nuclei, and neurotransmitters are involved in this process.


Subject(s)
Cerebral Cortex/physiopathology , Electric Stimulation Therapy , Seizures/physiopathology , Seizures/therapy , Spinal Cord/physiopathology , Vagus Nerve/physiology , Animals , Cerebral Cortex/blood supply , Cerebrovascular Circulation/physiology , Laminectomy , Lumbosacral Region , Male , Penicillins , Positron-Emission Tomography , Pyramidal Tracts/physiology , Seizures/chemically induced , Spinal Cord/surgery , Spinal Nerve Roots/physiopathology , Spinal Nerve Roots/surgery , Swine
12.
Heart Rhythm ; 1(1): 14-23, 2004 May.
Article in English | MEDLINE | ID: mdl-15851110

ABSTRACT

OBJECTIVE: The objective of this study was to test the hypothesis that on the epicardium of the in vivo human heart, ventricular fibrillation (VF) consists of chaotic small wavefronts that constantly change paths. BACKGROUND: Despite the significance of VF to cardiovascular mortality, little is known about the wavefronts that constitute VF in humans. METHODS: In 9 patients undergoing cardiac surgery, a single VF episode was induced by rapid pacing immediately after institution of cardiopulmonary bypass while recordings were made from 504 electrodes spaced 2 mm apart in a 20 cm(2) plaque held against the anterior left ventricle epicardium. A total of 26 segments of VF, each 2 s long, were analyzed. A computer algorithm identified individual wavefronts and classified them into groups that followed similar activation sequences. RESULTS: The mean activation rate was 5.8 +/- 1.8 (mean +/- SD) cycles/s. The wavefronts during each epoch were grouped into 9.4 +/- 7.1 different activation pathways, and 8.3 +/- 2.3 wavefronts followed each pathway. Individual wavefronts spread to activate an area of 5.1 +/- 3.0 cm(2) in the mapped region. The majority of the wavefronts propagated into the mapped region and/or propagated out of the mapped region into adjacent tissue, suggesting that the wavefronts were larger than 5.1 cm(2). Reentry was identified in only 16 of the 26 (62%) 2-s segments, always completed <2 cycles, and lasted for 9.5 +/- 6.6% of these 16 epochs, which is 5.8% of the total duration of all the segments analyzed. CONCLUSION: VF wavefronts on the human epicardium are usually large, repeatedly follow distinct pathways, and only occasionally reenter. If these results for the left ventricular epicardium are representative of those for the entire ventricular mass, they do not support the hypothesis that human VF consists of small, constantly changing wavefronts, but rather suggest that there is significant organization of human VF.


Subject(s)
Body Surface Potential Mapping , Pericardium/physiopathology , Ventricular Fibrillation/physiopathology , Action Potentials , Adult , Aged , Algorithms , Cardiopulmonary Bypass , Electrophysiologic Techniques, Cardiac , Female , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Prospective Studies , Time Factors
13.
Heart Rhythm ; 1(5): 616-23, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15851229

ABSTRACT

OBJECTIVES: The purposes of this study were to examine the first activations following atrial defibrillation shocks to help understand how and where atrial fibrillation (AF) relapsed following failed shocks and to assess the difference in postshock activation between failed and successful shocks. BACKGROUND: While many studies have investigated the mechanism of ventricular defibrillation, much less is known about the mechanisms of AF. METHODS: Sustained AF was induced electrically after pericardial infusion of methylcholine in 10 sheep. Biphasic subthreshold shocks were delivered to three configurations: right atrium to distal coronary sinus (RA-CS), sequential shocks with RA-CS as the first pathway followed by proximal CS to superior vena cava as the second pathway (Sequential), and right ventricle to superior vena cava plus can (V-triad). In eight sheep, global atrial mapping was performed with 504 electrodes spaced 3 to 4 mm apart. RESULTS: Earliest postshock activations mostly arose from the left atrium for V-triad but arose from either atrium for RA-CS and Sequential. Preshock AF cycle lengths were significantly shorter at the earliest activation sites than at seven of eight other sites globally distributed over both atria. In all type B successful episodes in which one or more rapid activations occurred after the shock and in 50 of the 72 failed episodes analyzed, activation fronts spread away from the earliest site in a focal pattern, and discrete nonfragmented activation complexes were present in the first derivatives of the electrograms. In the other 22 failed episodes, earliest activation fronts spread in a nonfocal pattern, and earliest postshock electrogram derivatives were fractionated. To better interpret the activation pattern in the fragmented regions, a 504 electrode plaque with 1.5-mm electrode spacing was placed on the right atrial appendage in two additional sheep. In 11 of 108 failed episodes, earliest postshock activation appeared inside the plaque and spread in a focal pattern with nonfragmented electrogram derivatives in 10 episodes and in a reentrant pattern with fragmented electrogram derivatives in the other. CONCLUSIONS: (1) The electrode configuration influenced the location of earliest postshock activation. (2) Earliest postshock activation occurred where the preshock AF cycle length was short. (3) Earliest activations following all type B successful and most failed episodes were not fragmented and spread in a focal pattern. (4) The region of earliest postshock activation in the failed episodes without a focal postshock activation pattern exhibited regions of fragmented electrogram derivatives that may represent conduction block and possibly reentry.


Subject(s)
Atrial Fibrillation/physiopathology , Electric Countershock , Electrophysiologic Techniques, Cardiac , Animals , Disease Models, Animal , Electrodes , Female , Heart Atria/physiopathology , Male , Methacholine Chloride/administration & dosage , Parasympathomimetics/administration & dosage , Sheep
14.
Pacing Clin Electrophysiol ; 26(9): 1824-36, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12930496

ABSTRACT

While it has been shown that pacing during ventricular fibrillation (VF) can capture a portion of the epicardium, little is known about the characteristics of the area captured or about whether adaptively changing the pacing rate during VF will increase the area captured. In six open-chested pigs, pacing during VF was performed from the center of a plaque containing 504 electrodes 2 mm apart in a21 x 24 array on the anterior right ventricle. Simultaneous recordings from the 504 electrodes were used to construct activation maps from which the area of epicardium captured by pacing was determined. Four pacing algorithms were examined: (1) fixed rate pacing at 95% of the median VF activation rate, (2 and 3) adaptive pacing in which the pacing timing and/or rate is reset in real time if capture is not obtained, and (4) pacing at a slowly increasing rate after initial capture. Regional capture, defined as control of the myocardium under at least 10 plaque electrodes, was achieved in 71% (92/129) of pacing episodes. The incidence of capture was not significantly different for pacing algorithms 1-3. The maximum area captured for each pacing episode with algorithms 1-3 was 3.8 +/- 2.0 cm2(mean +/- SD). Within each animal, the pattern of capture was similar among all pacing episodes, no matter which algorithm was use dr = 0.85 +/- 0.25). The region of greatest capture extended away from the pacing site along the long axis of the myocardial fibers. However, the area of captured epicardium toward the right ventricular side of the pacing electrode was 9.7 times greater than toward the left ventricular side. This principal direction toward the right ventricular side of the pacing electrode was the same direction traveled by the majority of VF activation fronts before capture occurred. The absence of recorded activations at the pacing site for 20 consecutive stimuli predicted 83% of the time that regional capture was present. With algorithm 4, the pacing rate could be increased 7.1%+/- 4.3%while maintaining capture; however, the area of capture progressively decreased as the pacing rate increased. While pacing from the anterior right ventricular epicardium during VF, the area of capture is repeatable and is markedly asymmetrical with almost 10 times as much epicardium captured on the side of the pacing electrode closest to the acute margin of the right ventricle as on the opposite side. This marked asymmetry is associated both with myofiber orientation and with the direction of spread of activation and hence the direction of dispersion of refractoriness during VF just before pacing is initiated. It is possible to perform adaptive pacing algorithms in real time during VF; however, the two adaptive algorithms tested did not capture significantly more epicardium than a simple fixed-rate pacing algorithm. Although it is possible to maintain capture while increasing the pacing rate during VF, the area of capture decreases.


Subject(s)
Algorithms , Cardiac Pacing, Artificial/methods , Ventricular Fibrillation/physiopathology , Animals , Electrodes, Implanted , Electrophysiologic Techniques, Cardiac , Swine , Ventricular Fibrillation/therapy
15.
Pediatr Neurosurg ; 36(6): 314-9, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12077476

ABSTRACT

OBJECTIVE: To determine a solution capable of discerning adipose versus nervous tissue, to aid in surgical separation of the adipose tissue which appears to be visually indistinguishable from nervous tissue in lipomyelomeningoceles (LMMs). METHODS: The following solutes (in normal saline) were investigated, both at 25 and 37 degrees C: beta-carotene, vitamin D, vitamin E, lecithin, hydrogen peroxide, lipase, protease, hyaluronidase, partially purified collagenase, purified collagenase, trypsin, trypsin plus purified collagenase and non-solute-containing saline (control). Each solution was applied to a pediatric lipoma to determine gross effects over a period of approximately 30 min. If a solution appeared to affect the adipose tissue grossly, studies of functional in vivo sensory evoked and spontaneous potentials using that particular solution were conducted upon sheep spinal cord, nerve roots, dura and peripheral nerve. Additionally, histological studies were conducted to determine the effect of that solution upon adipose tissue, spinal cord, myelin, dura and nerve roots. RESULTS: Of all solutions investigated, partially purified collagenase type 1 (T1C; Lot M0M4322, Code CLS-1, Worthington Biochemical Corporation, Lakewood, N.J., USA) at 37 degrees C was the most successful in grossly altering the consistency and appearance of adipose tissue. This change was more apparent over 20-30 min following application of the solution to the adipose tissue. Solutions not containing T1C did not show appreciable results; purified collagenase plus trypsin did not appear comparable or superior to T1C. No significant histological or functional change was noted when comparing the spinal cord, nerve rootlets, myelin, dura or peripheral nerve from the T1C-treated group versus normal (untreated) control groups. CONCLUSION: T1C appears to be a potentially effective solution for application during LMM surgery in the acute setting, and such use of an adjunct solution may significantly aid in the safe surgical resection of LMMs. Pending further research, this technique may be applied for other indications which require discernment or alteration of adipose versus nervous tissue.


Subject(s)
Adipose Tissue/drug effects , Adipose Tissue/pathology , Lipoma/pathology , Lipoma/surgery , Meningomyelocele/pathology , Meningomyelocele/surgery , Nerve Tissue/drug effects , Nerve Tissue/pathology , Pharmaceutical Solutions/chemistry , Pharmaceutical Solutions/pharmacology , Adipose Tissue/surgery , Chemotherapy, Adjuvant , Child , Collagenases/chemistry , Collagenases/pharmacology , Collagenases/therapeutic use , Humans , In Vitro Techniques , Lipoma/drug therapy , Meningomyelocele/drug therapy , Nerve Tissue/surgery , Pharmaceutical Solutions/therapeutic use , Time Factors
16.
Pediatr Neurosurg ; 36(5): 236-43, 2002 May.
Article in English | MEDLINE | ID: mdl-12053041

ABSTRACT

OBJECTIVE: To characterize the effects of stimulation of the nerve of Hering (HN; cranial nerve nine) in controlling seizure activity using a canine model. METHODS: Using penicillin applied topically to a region of the cerebral cortex, 16 seizure-type continuous epileptiform discharges were generated. Ten specimens of HN (five left-sided and five right-sided) were dissected from the cervical region in five dogs and stimulated at varying parameters to determine the effects in controlling epileptiform activity. Electroencephalography (using a multielectrode array), electrocardiography and other vital signs were continuously monitored for side effects. RESULTS: Resolution of continuous epileptiform activity following stimulation was found in 12 of 16 trials (75%); no spontaneous resolution was noted in the absence of stimulation, and stimulation significantly shortened seizure duration (p < 0.05). Mean epileptiform activity duration was 139 s prior to stimulation (range 1-432 s), with a mean poststimulation delay of 17 s until resolution and a mean interictal time of 399 s. Two specimens became free of seizure activity for the duration of our study (p < 0.001). No significant side effects (such as the potentially life-threatening cardiac problems seen with right-sided cervical vagal nerve stimulation) were found with stimulation of either left- or right-sided HN. Stimulation of other regional nerves (e.g. twelfth cranial nerve, nerves of the cervical plexus) failed to yield similar control of epileptiform activity. CONCLUSIONS: The results of this pilot study suggest that stimulation of the HN can successfully control focal seizure activity in the majority of cases. Pending further study, stimulation of the HN may have a role in the management of patients suffering from medically and otherwise surgically refractory epilepsy.


Subject(s)
Electric Stimulation Therapy , Epilepsy/prevention & control , Glossopharyngeal Nerve/physiology , Animals , Dogs , Electric Stimulation Therapy/adverse effects , Electric Stimulation Therapy/methods , Electroencephalography , Epilepsy/diagnosis , Models, Animal , Neurosurgical Procedures/methods
17.
Circulation ; 105(21): 2537-42, 2002 May 28.
Article in English | MEDLINE | ID: mdl-12034662

ABSTRACT

BACKGROUND: Shocks that have defibrillated spontaneous ventricular fibrillation (VF) during acute ischemia or reperfusion may seem to have failed if VF recurs before the ECG amplifier recovers after shock. This could explain why the defibrillation threshold (DFT) for spontaneous VF appears markedly higher than for electrically induced VF. METHODS AND RESULTS: The DFT for electrically induced VF (E-DFT) was determined in 15 pigs before ischemia, followed by left anterior ascending or left circumflex artery occlusion. VF was electrically induced 20 minutes after occlusion, followed 5 minutes later by reperfusion. Whether spontaneous or electrically induced, VF during occlusion or reperfusion was treated with up to 3 shocks at 1.5xE-DFT. If all 3 shocks failed, shock strength was increased. Thirty minutes after reperfusion, the other artery was occluded and the protocol was repeated. Defibrillation was considered successful if postshock sinus/idioventricular rhythm was present for > or = 30 seconds. VF recurring within 30 seconds after the shock was considered immediate or delayed if the first postshock activation complex in a rapidly restored ECG recording was VF or sinus/idioventricular rhythm, respectively. Defibrillation efficacy at 1.5xE-DFT was significantly higher for electrically induced ischemic VF (76%) than for spontaneous VF (31%). The incidence of delayed recurrence after electrically induced nonischemic (3%) or ischemic (20%) VF was significantly lower than after spontaneous VF (75%). Mean VF recurrence time after spontaneous VF was 4.6+/-5.3 seconds. CONCLUSIONS: Spontaneous VF can be halted by a shock but then quickly restart before a standard ECG amplifier has recovered from postshock saturation, making it appear that the shock failed.


Subject(s)
Electric Countershock/methods , Heart Conduction System/physiopathology , Myocardial Ischemia/physiopathology , Myocardial Reperfusion , Ventricular Fibrillation/physiopathology , Animals , Disease Models, Animal , Electrocardiography , Electrophysiologic Techniques, Cardiac/methods , Female , Male , Myocardial Ischemia/complications , Recurrence , Swine , Time Factors , Treatment Outcome , Ventricular Fibrillation/complications
18.
Ann Biomed Eng ; 30(2): 180-91, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11962770

ABSTRACT

An intelligent multichannel stimulator (IMS) has been designed and built for use in a cardiac research environment. The device is capable of measuring and responding to cardiac electrophysiological phenomena in real time with carefully timed and placed electrical stimuli. The system consists of 16 channels of sense/stimulation electronics controlled by a digital signal processor (DSP) data acquisition card and a host computer and can be expanded to include more channels. The DSP allows for powerful and flexible algorithms to be implemented for real-time interaction with the cardiac tissue. Although a number of possible uses can be conceived for such a device, the initial motivation was to improve upon attempts to terminate fibrillation by pacing. The IMS was tested in an open-chest animal model, both in sinus rhythm and during fibrillation. It was shown to be an effective research tool by demonstrating the ability to measure and respond to cardiac activations in real time using complex numerical algorithms and appropriately timed stimuli.


Subject(s)
Arrhythmias, Cardiac/therapy , Artifacts , Atrial Fibrillation/physiopathology , Electrocardiography/instrumentation , Pacemaker, Artificial , Ventricular Fibrillation/therapy , Algorithms , Animals , Arrhythmias, Cardiac/physiopathology , Atrial Fibrillation/therapy , Body Surface Potential Mapping/instrumentation , Body Surface Potential Mapping/methods , Electrocardiography/methods , Electrodes , Electrophysiologic Techniques, Cardiac , Equipment Design , Feedback , Humans , Sensitivity and Specificity , Signal Processing, Computer-Assisted , Swine , Ventricular Fibrillation/physiopathology
19.
Pacing Clin Electrophysiol ; 25(1): 42-8, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11877936

ABSTRACT

This study tested the hypothesis that the DFT could be lowered by delivering a weak auxiliary shock in conjunction with a stronger primary shock with the auxiliary shock electrode near the cardiac region where the primary shock electric field is weakest. This hypothesis was tested by determining the DFTs with the auxiliary shock delivered from different locations within the great cardiac vein (GCV). In 15 dogs, catheters with defibrillation electrodes were placed transvenously in the RV apex, the SVC, and the GCV. An active can electrode and the SVC electrodes were electrically coupled to serve as a return electrode for the RV and GCV electrodes. DFTs were determined for a primary shock through the RV electrode with and without a subsequent auxiliary shock of lower amplitude through the GCV electrode. The leading edge voltage and current at DFT were significantly lowered by addition of the auxiliary shock (17% and 19% decreased, respectively), but energy was not changed. The animals were divided into three groups according to the location of the GCV electrode. The leading edge voltage, current, and total delivered energy at the DFT were significantly lower in animals with the GCV electrode near the apex (22%, 24%, and 13% reduction, respectively) compared with those where the GCV electrode was positioned away from apex (8%, 10% reduction and 18% increase, respectively, P < 0.001). Application of an auxiliary shock to the apical region, near the region where previous studies have indicated that the RV primary shock has its weakest effects, caused the greatest decrease in DFT.


Subject(s)
Coronary Vessels/physiopathology , Electric Countershock , Ventricular Fibrillation/physiopathology , Animals , Catheterization , Differential Threshold , Dogs , Electric Stimulation Therapy , Electrodes
SELECTION OF CITATIONS
SEARCH DETAIL